Skip to main content
SpringerLink
Log in

Ribonuclease-sensitive ribosomal vaccines

  • Pathogenicity And Medical Microbiology
  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

Abstract

This paper presents an analysis of the protective properties of the components in ribonuclease (RNase)-sensitive ribosomal vaccines, in particular the ribonucleic acid (RNA). The protective activities in mice of purified ribosomes derived fromPseudomonas aeruginosa and fromListeria monocytogenes were compared. Both ribosomal vaccines had to be combined with the adjuvant dimethyldioctadecylammonium bromide (DDA) in order to be protective, and both lost their activity after RNase treatment. The ribosomal vaccines as well as RNA purified from the ribosomes induced non-specific protection. Intraperitoneal injection of RNA with DDA induced an influx of peritoneal cells. Furthermore, RNA with DDA activated macrophages as shown by, a.o., enhanced phagocytic activity and killing capacity forL. monocytogenes. The results suggest that the observed macrophage activation is probably T-cell-independent. With regard to the ribosomal vaccine ofP. aeruginosa it is concluded that RNA also contributed to the protective activity by increasing the humoral response against suboptimal concentrations of contaminating cell surface antigens.

In conclusion, it is proposed that ribosomal vaccines may be considered as a combination of a non-specific immunomodulator (RNA) with pathogen-specific cell surface antigens. This concept of ribosomal vaccines is discussed in relation to the literature concerning RNase-sensitive ribosomal vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andron, L. A. andEigelsbach, H. T. 1975. Biochemical and immunological properties of ribonucleic acid rich extracts fromFrancisella tularensis. — Infect. Immun.12: 137–142.

    PubMed  Google Scholar 

  • Antonissen, A. C. J. M., Lemmens, P. J. M. R., Gonggrijp, R., Van den Bosch, J. F. andVan Boven, C. P. A. 1985a. RNase-sensitive and RNase-insensitive protective components isolated fromListeria monocytogenes. — Antonie van Leeuwenhoek51 (in press).

  • Antonissen, A. C. J. M., Lemmens, P. J. M. R., Kolfschoten-Gonggrijp, R., Van den Bosch, J. F. andVan Boven, C. P. A. 1983. Ribosomal and non-ribosomal protective components isolated fromListeria monocytogenes. — Antonie van Leeuwenhoek49: 611.

    Article  Google Scholar 

  • Antonissen, A. C. J. M., Lemmens, P. J. M. R., Van den Bosch, J. F. andVan Boven, C. P. A. 1985b. Comparison of enhanced resistance and delayed-type hypersensitivity induced with subcellular preparations fromListeria monocytogenes. — Antonie van Leeuwenhoek Rep.51 (in press).

  • Araujo, F. G. andRemington, J. S. 1974. Protection againstToxoplasma gondii in mice immunized with toxoplasma cell fractions, RNA and synthetic polyribonucleotides. — Immunology27: 711–721.

    CAS  PubMed  Google Scholar 

  • Au, C. C. andEisenstein, T. K. 1981. Nature of the cross-protective antigen in subcellular vaccines ofStreptococcus pneumoniae. — Infect. Immun.31: 160–168.

    CAS  PubMed  Google Scholar 

  • Baba, T. 1977. Immunogenic activity of a ribosomal fraction obtained fromPasteurella multocida. — Infect. Immun.15: 1–6.

    CAS  PubMed  Google Scholar 

  • Cooper, M. D., Tewari, R. P. andBowser, D. V. 1980. Immunogenicity of ribosomal preparations fromNeisseria gonorrhoeae. — Infect. Immun.28: 92–100.

    CAS  PubMed  Google Scholar 

  • Dussourd d’Hinterland, L., Pinel, A. M. andRey, G. 1980. Immunological study. — Drug Res.30: 132–141.

    CAS  Google Scholar 

  • Eisenstein, T. K. 1975. Evidence for O antigens as the antigenic determinants in ribosomal vaccines prepared fromSalmonella. — Infect. Immun.12: 364–377.

    CAS  PubMed  Google Scholar 

  • Eisenstein, T. K. 1978. Ribosomal vaccines: a review. p. 211–222.In A. Voller and H. Friedman (eds), New Trends and Developments in Vaccines. — MTP Press, Lancaster.

    Google Scholar 

  • Eisenstein, T. K., Angerman, C. R. andDeakins, L. W. 1981. Ribosomal vaccines as immunomodulators. p. 199–214.In H. Friedman, T. W. Klein and A. Szentivanyi (eds), Immunomodulation by Bacteria and their Products. — Plenum Press, New York.

    Google Scholar 

  • Feit, C. andTewari, R. P. 1974. Immunogenicity of ribosomal preparations from yeast cells ofHistoplasma capsulatum. — Infect. Immun.10: 1091–1097.

    CAS  PubMed  Google Scholar 

  • Field, L. H., Parker, C. D., Manclark, C. R. andBerry, L. J. 1979. Evaluation of a ribosomal vaccine against pertussis. — Infect. Immun.24: 346–351.

    CAS  PubMed  Google Scholar 

  • Gonggrijp, R., Mullers, W. J. H. A., Dullens, H. F. J. andVan Boven, C. P. A. 1984. Immunomodulation by ribosomal ribonucleic acid fromPseudomonas aeruginosa combined with dimethyl dioctadecylammonium bromide: adjuvant activity, nonspecific enhancement of antibacterial resistance and increased antitumor activity of macrophages. — Proc. 25th Dutch Fed. Meeting, Rotterdam, Fed. Med. Sci. Soc., Abstr. no 141.

  • Gonggrijp, R., Mullers, W. J. H. A., Lemmens, P. J. M. R. andVan Boven, C. P. A. 1980. Ribonuclease sensitive ribosomal vaccine ofPseudomonas aeruginosa. — Infect. Immun.27: 204–210.

    CAS  PubMed  Google Scholar 

  • Gonggrijp, R., Mullers, W. J. H. A. andVan Boven, C. P. A. 1981a. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine ofPseudomonas aeruginosa. — Infect. Immun.33: 178–185.

    CAS  PubMed  Google Scholar 

  • Gonggrijp, R., Mullers, W. J. H. A. andVan Boven, C. P. A. 1983. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide ofPseudomonas aeruginosa: a comparative study. — Antonie van Leeuwenhoek49: 173–182.

    Article  CAS  PubMed  Google Scholar 

  • Gonggrijp, R., Volleberg, M. P. W., Lemmens, P. J. M. R. andVan Boven, C. P. A. 1981b. Evidence for the presence of lipopolysaccharide in a ribonuclease sensitive ribosomal vaccine ofPseudomonas aeruginosa. — Infect. Immun.31: 896–905.

    CAS  PubMed  Google Scholar 

  • Hahn, H. andKaufmann, S. H. E. 1981. The role of cell-mediated immunity in bacterial infections. — Rev. Infect. Dis.3: 1221–1250.

    CAS  PubMed  Google Scholar 

  • Johnson, W. 1973. Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated fromSalmonella typhimurium. — Infect. Immun.8: 395–400.

    CAS  PubMed  Google Scholar 

  • Kolfschoten-Gonggrijp, R. 1982. Studies on the protective components in a ribonuclease sensitive ribosomal vaccine ofPseudomonas aeruginosa. — Thesis, University of Limburg, Maastricht.

  • Medina, S., Vas, S. J. andRobson, H. G. 1975. Effect of non-specific stimulation on the defence mechanisms of inbred mice. — J. Immunol.114: 1720–1725.

    CAS  PubMed  Google Scholar 

  • Misfeldt, M. L. andJohnson, W. 1976. Variability of protection in inbred mice induced by a ribosomal vaccine prepared fromSalmonella typhimurium. — Infect. Immun.14: 652–659.

    CAS  PubMed  Google Scholar 

  • Misfeldt, M. L. andJohnson, W. 1978. Protective ability ofSalmonella ribosomal protein and RNA in inbred mice. — Infect. Immun.21: 286–291.

    CAS  PubMed  Google Scholar 

  • Misfeldt, M. L. andJohnson, W. 1979. Identification of protective cell surface proteins in ribosomal fractions fromSalmonella typhimurium. — Infect. Immun.24: 808–816.

    CAS  PubMed  Google Scholar 

  • Riottot, M. M., Fournier, J. M. andJouin, H. 1981. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity ofKlebsiella pneumoniae ribosomal preparations — Infect. Immun.31: 71–77.

    CAS  PubMed  Google Scholar 

  • Tewari, R. P. 1975. Immunization against histoplasmosis. p. 441–452.In E. Neter and F. Milgrom (eds), The Immune System and Infectious Diseases. Fourth Int. Conv. Immunol., Buffalo, N. Y., 1974. — S. Karger Verlag AG, Basel.

    Google Scholar 

  • Thompson, H. C. W. andSnyder, J. S. 1971. Protection against pneumococcal infection by a ribosomal preparation. — Infect. Immun.3: 16–23.

    CAS  PubMed  Google Scholar 

  • Van den Bosch, J. F., Kanis, I. Y. R., Antonissen, A. C. J. M. andVan Boven, C. P. A. 1985. Mechanism of protection induced by ribosomal ribonucleic acid fromListeria monocytogenes. — Antonie van Leeuwenhoek Rep.51 (in press).

  • Wiesinger, A. andBorel, J. F. 1979. Studies on the mechanism of action of cyclosporin A. — Immunobiology156: 454–463.

    Google Scholar 

  • Willers, J. M. N., Bloksma, N., Van der Meer, C., Snippe, H., Van Dijk, H., De Reuver, M. J. andHofhuis, F. M. A. 1979. Regulation of the immune response by macrophages. — Antonie van Leeuwenhoek45: 41–48.

    Article  CAS  PubMed  Google Scholar 

  • Youmans, A. S. andYoumans, G. P. 1965. Immunogenic activity of a ribosomal fraction obtained fromMycobacterium tuberculosis. — J. Bacteriol.89: 1291–1298.

    CAS  PubMed  Google Scholar 

  • Youmans, A. S. andYoumans, G. P. 1966. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated fromMycobacterium tuberculosis. — J. Bacteriol.91: 2146–2154.

    CAS  PubMed  Google Scholar 

  • Youmans, A. S. andYoumans, G. P. 1974. The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines. — J. Immunol.112: 271–284.

    CAS  PubMed  Google Scholar 

  • Youmans, G. P. 1979. The nature of the immunizing activity of mycobacterial and other ribosomal and RNA vaccines. p. 268–276.In G. P. Youmans (ed.), Tuberculosis. — W. B. Saunders Co., Philadelphia.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, University of Limburg, P. O. Box 616, 6200 MD, Maastricht, The Netherlands

    R. Gonggrijp, A. C. J. M. Antonissen, J. F. van den Bosch & C. P. A. van Boven

Authors
  1. R. Gonggrijp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. C. J. M. Antonissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. F. van den Bosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. P. A. van Boven
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonggrijp, R., Antonissen, A.C.J.M., van den Bosch, J.F. et al. Ribonuclease-sensitive ribosomal vaccines. Antonie van Leeuwenhoek 50, 763–774 (1984). https://doi.org/10.1007/BF02386239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02386239

Keywords

Search

Navigation